CHROMOCELL THERAPEUTICS CORPORATION AMENDED AND RESTATED CONSULTANT AGREEMENTConsultant Agreement • June 30th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionThis Amended and Restated Consultant Agreement (the “Agreement”) is dated June 23, 2023, effective as of May 15, 2023 (the “Effective Date”), by and between Chromocell Therapeutics Corporation (“CTC” or the “Company”) and Camden Capital LLC (“Consultant”). Collectively, the Company and Consultant may be referred to herein as the “Parties” or each individually as a “Party.”
CHROMOCELL THERAPEUTICS CORPORATION CONSULTANT AGREEMENTConsultant Agreement • January 20th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 20th, 2023 Company Industry JurisdictionThis Consultant Agreement (the “Agreement”) is made and entered into this 9th day of January, 2023 (the “Effective Date”) by and between Chromocell Therapeutics Corporation (“CTC” or the “Company”) and Camden Capital LLC (“Consultant”). Collectively, the Company and Consultant may be referred to herein as the “Parties” or each individually as a “Party.”